In this video, Alliance for Aging Research President and CEO Susan Peschin, MHS, talks about the Centers for Medicare and Medicaid Services’ decision to reconsider its coverage of a minimally-invasive heart valve disease treatment called transcatheter aortic valve replacement, or TAVR. The details of how CMS decides to cover and reimburse hospitals for TAVR are very important because they will impact how many hospitals and heart centers around the country will be able to offer the procedure. The Alliance for Aging Research is asking you to weigh in with your personal story about heart valve disease or TAVR by submitting comments to CMS.
The deadline to submit comments on this coverage policy is July 27, 2018.
Visit www.agingresearch.org/TAVR or www.heartvalvevoice-us.org to learn how to submit your comments before the deadline.
source
